We read the article by Hallifax et al 1 in an issue of CHEST (October 2014) and are very interested in their fi ndings. We appreciate their achievement in ultrasoundguided biopsy for diagnosing pleural lesions, especially for patients who cannot undergo thoracoscopic biopsy. However, we also have some opinions on the issue.
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Transthoracic Needle Biopsy for Pleural and Peripheral Lung Lesions Ultrasonography vs CT Scan Guidance

To the Editor:
We read the article by Hallifax et al 1 in an issue of CHEST (October 2014) and are very interested in their fi ndings. We appreciate their achievement in ultrasoundguided biopsy for diagnosing pleural lesions, especially for patients who cannot undergo thoracoscopic biopsy. However, we also have some opinions on the issue.
It is well known that imaging-guided biopsy for pulmonary lesions will induce complications such as pneumothorax and bleeding. Preoperative enhanced CT imaging or intraoperative color Doppler ultrasound can be used to evaluate the vessel and avoid or reduce the operationrelated bleeding. However, the potential occurrence of pneumothorax makes us avoid performing CT scanguided biopsies. Th e occurrence of pneumothorax will result in prolonged operation time, lower oxygen saturation in patients with senility, and even failure of biopsy. We notice that Hallifax et al 1 perfectly reduced the incidence of complications including pneumothorax (0 of 50 procedures [0.0%]). In an article by Sconfi enza et al, 2 the incidence of pneumothorax was six in 103 patients (5.8%) and 25 in 170 patients (14.7%) in ultrasound-and CT scan-guided fi ne-needle aspiration biopsy procedures for diagnosing pleural/peripheral lung lesions, respectively.
Our imaging center has a 20-year history of performing CT scan-guided transthoracic needle biopsies and has treated a total of 2,400 cases. According to our experiences, the incidence of pneumothorax following CT scan-guided biopsy of pleural and subpleural lesions was about 20%, and pneumothorax occurred more frequently when the lesions were small. Th e incidence of pneumothorax in our center is slightly higher than that of Hallifax et al, 1 but is not unduly high . According to a recent review, the incidence of pneumothorax following CT scan-guided biopsy is 9% to 54%. 3 Based on these results, we agree with Sconfi enza et al 2 that ultrasound guidance should be recommended for biopsy of pleural and peripheral lung lesions.
According to previous research, the presence of emphysema is one major cause that induces pneumothorax. 3 However, Hallifax et al 1 did not mention this factor in their study, nor did they explain why thoracoscopy failed in 13 cases. In our experience, pneumothorax will commonly occur in patients with apparent emphysema, especially when pulmonary bullae are unavoidable in the focus puncture path. We already listed emphysema as the relative contraindication of this operation, since it may induce lifethreatening pneumothorax. Moreover, pneumothorax is very likely to occur when peripheral lesions are close to the pleura, especially when the peripheral lesions do not obviously invade or adhere to the pleura. Thus, Hallifax et al 1 should further elaborate the relevant patients' clinical data.
Moreover, we hold that the 1-h observation aft er imaging-guided transthoracic needle biopsy may be very short. We prolong the postoperative observation period to 24 h, so as to avoid the occurrence of delayed pneumothorax. We thank Dr Liang and colleagues for their comments and concern about the lack of pneumothoraces as complications in our data 1 compared with another published study. 2 We would like to point out that these and previous data report pneumothorax rates aft er both pulmonary and pleural biopsies. Sconfi enza et al 2 do not separate out the pneumothorax rate for ultrasoundguided biopsies of pleural lesions alone. Th e series reported by Boskovic et al 3 was entirely composed of CT scan-guided lung biopsies. All of our biopsies were performed on the pleura alone in patients with at least small pleural eff usions (hence being considered for thoracoscopy). Lung parenchyma was specifi cally avoided with real-time ultrasound guidance, thereby drastically reducing our pneumothorax rate. Th e risk of blind pleural biopsy would clearly be higher.
Th e comment of Dr Liang and colleagues regarding the additional increased risk in emphysematous lung disease would be signifi cant if the lung parenchyma were being biopsied. In our experience, patients with severe COPD are oft en not considered for medical thoracoscopy, due to increased physical frailty, reduced performance status, and because the raised intrinsic lung pressure may result in diffi culty collapsing the lung, which is required for thoracoscopy to be successful.
With respect to why patients "failed thoracoscopy," the reasons for this were already outlined in our original article and include patient frailty, heavily loculated/septated pleural fl uid, or lung adherent to the chest wall. To reduce failure rates, all patients are assessed in clinic prior to their procedure; however, in a small number of cases, these factors change on the day of the procedure. Our work highlights that in this scenario, ultrasound-guided biopsy can provide a high yield of pleural tissue for diagnosis.
Th e authors know of no robust published evidence to support the practice of admitting the patient overnight for 24 h, as Dr Liang and colleagues suggest, particularly for ultrasound-guided biopsy of the parietal pleura. Th e 1-h observational period is common practice in day-case procedures performed by both physicians and radiologists in the United Kingdom; in our experience of . 3,000 pleural procedures over the last 8 years, this has proven suffi cient to identify complications that might arise. 
